ATCC 100 Years Logo Anniversary ATCC 100 Years Logo Anniversary Cart 0
  • Quick Order
  • Careers
  • Support

2024 News Releases

Virologist filling a syringe researching vaccine in laboratory bench October 30, 2024

ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development

ATCC awarded a one-year, subaward in the amount of $165,962 from NIAID to collaborate on babesiosis and tickborne disease research.

Glass bottles in production in the tray of an automatic liquid dispenser October 23, 2024

ATCC Receives Grant from NIH to Build New Biomanufacturing Suite at its Manassas Headquarters

ATCC received a C06 Research Facilities Construction Grant from ORIP, part of the NIH, to support the building of ATCC’s new biomanufacturing suite at its headquarters in Manassas, VA.

Modern microscope with digital imaging system in the lab September 26, 2024

ATCC Announces Award from NIAID to Support Preclinical Models of Infectious Diseases

ATCC awarded an IDIQ contract by NIAID to support its Division of Microbiology and Infectious Diseases (DMID) in infectious disease treatment and research.

ATCC Building September 12, 2024

ATCC Receives COF Grant to Apply Toward Its New Biomanufacturing Suite in VA

ATCC received a COF grant administered by the Virginia Economic Development Partnership (VEDP) to apply toward its new biomanufacturing suite at its Manassas headquarters

Blue DNA double helix strand in 3D illustration May 29, 2024

ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases

ATCC was awarded a task order with a ceiling value of $15.5 million from NIAID to develop well-characterized challenge material (WCCM) for the In Vitro Assessment for Antimicrobial Activity (IVAAA) program.

Close up of human hand putting the test tube to centrifuge March 19, 2024

ATCC Announces Award from the NCI to Provide Biospecimen Processing Services and Assays for Cancer Research

NCI awarded ATCC a five-year contract with a ceiling value of $7.37 million to provide biospecimen processing services and assays for cancer research.

fluorescent heart February 27, 2024

ATCC and Tissue Dynamics Announce Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market

ATCC and Tissue Dynamics announced a partnership to develop workflow-friendly cardiac organoid-based kits for improved cardiac safety testing in drug development.

Gloved hand holding sample tube, rack of sample tubes January 04, 2024

ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen

ATCC announced a 5-year, $87 million award from BARDA to support the development of next-generation medical countermeasures.